Advertisement

Topics

Cancer Research UK and NU agree three-year research Astex Pharma deal

04:08 EDT 17 Aug 2017 | Pharmafile

Cancer Research UK and Newcastle University have announced that their existing research collaboration with Astex Pharmaceuticals will be extended for a further three years. The alliance was formed five years ago, aiming to discover new drug candidates to be brought through to patients.

read more

Original Article: Cancer Research UK and NU agree three-year research Astex Pharma deal

NEXT ARTICLE

More From BioPortfolio on "Cancer Research UK and NU agree three-year research Astex Pharma deal"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.